Abstract
The immunogenicity of “novel” MART-1 and Tyrosinase class-II peptides was assessed in transgenic mice. Tyrosinase141-161 peptide was found to be immunogenic and endogenously processed in the HLA-DRβ1*0101 and HLADR β1*0401 transgenic mice with peptide specific production of IFNγ or IL-5 respectively. The MART-129-43 peptide was only found immunogenic in HLA-DRβ1*0101 mice.
Keywords: mhc class, peptides, cd t cells, vitamin e, dendritic cells
Protein & Peptide Letters
Title: Identification of Immunogenic MHC Class II Tyrosinase-Derived Peptides Using HLA-DR1 and HLA-DR4 Transgenic Mice
Volume: 14 Issue: 5
Author(s): R. B.V. Horton, S. A.S. Laversin, S. P. Reeder, R. C. Rees and S. E.B. McArdle
Affiliation:
Keywords: mhc class, peptides, cd t cells, vitamin e, dendritic cells
Abstract: The immunogenicity of “novel” MART-1 and Tyrosinase class-II peptides was assessed in transgenic mice. Tyrosinase141-161 peptide was found to be immunogenic and endogenously processed in the HLA-DRβ1*0101 and HLADR β1*0401 transgenic mice with peptide specific production of IFNγ or IL-5 respectively. The MART-129-43 peptide was only found immunogenic in HLA-DRβ1*0101 mice.
Export Options
About this article
Cite this article as:
Horton B.V. R., Laversin A.S. S., Reeder P. S., Rees C. R. and McArdle E.B. S., Identification of Immunogenic MHC Class II Tyrosinase-Derived Peptides Using HLA-DR1 and HLA-DR4 Transgenic Mice, Protein & Peptide Letters 2007; 14 (5) . https://dx.doi.org/10.2174/092986607780782768
DOI https://dx.doi.org/10.2174/092986607780782768 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Isoliquiritigenin (ISL) and its Formulations: Potential Antitumor Agents
Current Medicinal Chemistry Proceedings of the 1<sup>st</sup> Puerto Rico Biobanking Workshop
Reviews on Recent Clinical Trials Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Current Cancer Drug Targets Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
Current Medicinal Chemistry Tumor Necrosis Factor: How to Make a Killer Molecule Tumor-Specific?
Current Cancer Drug Targets Molecularly Guided Therapy of Neuroblastoma: A Review of Different Approaches
Current Pharmaceutical Design Safety of Multi-Targeted Kinase Inhibitors as Monotherapy Treatment of Cancer: A Systematic Review of the Literature
Current Drug Safety Topical and Transdermal Delivery of Drug-Loaded Nano/ Microsystems with Application of Physical Enhancement Techniques
Current Drug Targets Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review
Current Molecular Pharmacology Lutetium-177 Labeled Bombesin Peptides for Radionuclide Therapy
Current Radiopharmaceuticals Arachidonic Acid Induces the Migration of MDA-MB-231 Cells by Activating Raft-associated Leukotriene B4 Receptors
Clinical Cancer Drugs New Directions for Clinical Trials of Targeted Alpha Therapy for Metastatic Melanoma
Current Radiopharmaceuticals Frailty of Older Age: The Role of the Endocrine - Immune Interaction
Current Pharmaceutical Design Recent Developments in Patented DC-Based Immunotherapy for Various Malignancies
Recent Patents on Regenerative Medicine Role of Genetic and Epigenetic Factors in Oral Squamous Cell Carcinoma - A Structured Review
Recent Patents on Biomarkers Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis
Current Drug Targets Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Maxillary Metastasis of Esophageal Cancer: Report of the First Case and Literature Review
Combinatorial Chemistry & High Throughput Screening In Search of the Most Suitable Lentiviral shRNA System
Current Gene Therapy Cellular Senescence in the Development and Treatment of Cancer
Current Pharmaceutical Design